ABSTRACT
Biosynthetic gene clusters (BGCs) are a subset of consecutive genes present within a variety of organisms to produce specialized metabolites (SMs). These SMs are becoming a cornerstone to produce multiple medications including antibacterial and anticancer agents. Natural products (NPs) also play a pivotal role in enhancing the virulence of ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.), which represent a global health threat. We aimed to sequence and computationally analyze the BGCs present in 66 strains pertaining to three different ESKAPE pathogenic species: 21 A. baumannii, 28 K. pneumoniae, and 17 P. aeruginosa strains recovered from clinical settings in Egypt. DNA was extracted using QIAamp DNA Mini kit and Illumina NextSeq 550 was used for whole-genome sequencing. The sequences were quality-filtered by fastp and assembled by Unicycler. BGCs were detected by antiSMASH, BAGEL, GECCO, and PRISM, and aligned using Clinker. The highest abundance of BGCs was detected in P. aeruginosa (590), then K. pneumoniae (146) and the least in A. baumannii strains (133). P. aeruginosa isolates shared mostly the non-ribosomal peptide synthase (NRPS) type, K. pneumoniae isolates shared the ribosomally synthesized and post-translationally modified peptide-like (RiPP-like) type, while A. baumannii isolates shared the siderophore type. Most of the isolates harbored non-ribosomal peptide (NRP) BGCs with few K. pneumoniae isolates encoding polyketide BGCs. Sactipeptides and bottromycin BGCs were the most frequently detected RiPP clusters. We hypothesize that each species’ BGC signature confers its virulence. Future experiments will link the detected clusters with their species and determine whether the encoded SMs are produced and cause their virulence.
IMPORTANCE
Our study analyzes the biosynthetic gene clusters (BGCs) present in 66 assemblies from clinical ESKAPE pathogen isolates pertaining to Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa strains. We report their sequencing and assembly followed by the analysis of their BGCs using several bioinformatics tools. We then focused on the most abundant BGC type in each species and we discussed their potential roles in the virulence of each species. This study is pivotal to further build on its experimental work that deciphers the role in virulence, possible antibacterial effects, and characterization of the encoded specialized metabolites (SMs). The study highlights the importance of studying the “harmful” BGCs and understanding the pathogenicity and virulence of those species, as well as possible benefits if the SMs were used as antibacterial agents. This could be the first study of its kind from Egypt and would shed light on BGCs from ESKAPE pathogens from Egypt.
KEYWORDS: ESKAPE pathogens, specialized metabolites, biosynthetic gene clusters, natural products
INTRODUCTION
The ESKAPE term refers to a group of pathogens causing alarming infections in both developed and developing countries due to increasing multidrug resistance and virulence. They include Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanni, Pseudomonas aeruginosa, and Enterobacter species (1). According to the 2019 antimicrobial resistance threat report issued by the Centers for Disease Infection and Control (CDC), all members of ESKAPE pathogens are seriously threatening on the nosocomial and community levels in the USA (2). In 2017, the World Health Organization published a priority list of bacterial pathogens for which research and development should be urgently directed to develop new antibiotics. Multidrug-resistant A. baumanni, P. aeruginosa, and Enterobacteriaceae are among the critical pathogens listed for new antibiotic development (3). Thus, all the ESKAPE pathogens group species can be considered superbugs that resist most of the commonly known antibiotics. In addition to being reported as multidrug resistant, ESKAPE pathogens are also reported to be hypervirulent (4).
These pathogens are developing antimicrobial resistance (AMR) against most of the last-line antibiotics such as carbapenems, extended-spectrum beta-lactams (ESBLs), vancomycin, and methicillin (2). Bacterial cells can have intrinsic resistance genes encoded on their chromosomes or can acquire extrachromosomal genes carried on mobile genetic elements such as plasmids and transposons (5). ESBLs are capable of degrading third-generation cephalosporins in addition to penicillin, first- and second-generation cephalosporins, and aztreonam. ESBLs are plasmid-encoded resistance genes and have different types, where the most common are sulfhydryl reagent variable (SHV), TEM, CTX-M, and oxacillinases (OXA) (6). While carbapenem is effective against both Gram-positive and Gram-negative bacteria, carbapenem resistance is a major public threat of infections caused by Gram-negative pathogens. Modifications in penicillin-binding proteins (PBPs), the increase in efflux pumps, and reduction in cell membrane permeability are among the resistance mechanisms to carbapenems (7). Methicillin-resistance S. aureus is able to express a variant of PBP, PBP2a, to which methicillin has lower binding affinity (8).
The healthcare system in Egypt is currently struggling with multidrug resistance bacteria in both hospital- and community settings. The misuse and abuse of antibiotics play a key role in the uncontrolled resistance phenomenon. Individuals have easier access to antibiotics as over-the-counter medications instead of being prescribed by healthcare specialists (9). Routine infection control measures in hospitals and reporting resistance cases are cornerstones to systematically tackle AMR issues (10). More effort should be invested to routinely isolate, sequence and study highly prevalent nosocomial and community pathogens and how far or closely related they are compared to their global counterparts.
Some organisms, including bacteria, fungi, and plants, possess in their genomes biosynthetic gene clusters (BGCs) that are encoding for the ultimate synthesis of specialized metabolites (SMs) (11, 12). SMs confer more benefits to the producing organism such as antagonism (e.g., bacteriocins), communication (e.g., homoserine lactones), and survival in harsh environments (e.g., ectoine) (13). SMs are chemically diverse compounds comprising an array of types including polyketides, peptides, terpenes, and others (14). SMs are also known as natural products (NPs, they are encoded in the host genome and are produced by several organisms including pathogens (15, 16).
In addition to the antibiotic activity of a plethora of SMs, as well as SMs of anticancer activity and their use as FDA-approved natural products later on, e.g., erythromycin and doxorubicin, respectively (17); other SMs are contributing to the virulence of their producing organism, e.g., the fungal toxin dihydroxynaphthalene melanin (18).
SMs are more commonly studied and known for their advantageous effects, e.g., as antibacterial agents. Nevertheless, SMs can also have pathogenic effects and can increase the virulence of pathogens producing SMs. Among the examples are Streptomyces pathogenic strains that produce geldanamycin and nigericin as SMs and they were reported to have toxic effects on plants (19). It is thus of ultimate importance to study the SMs and their BGCs within pathogenic strains for better understanding and targeting of pathogenicity and virulence of such strains. Other pathogenic strains also were proved to produce SMs that cause harm to their host insects and arthropods (20). SMs were also recently investigated in P. aeruginosa clinical isolates as to their metabolites and their structures and were found to produce siderophores, rhamnolipids, quinolones, and phenazines (21). Other examples are Burkholderia pathogenic strains and SMs they produce, such as toxoflavin produced by the pathogenic Burkholderia glumae (22). It remains interesting to probe pathogenic microbes both for SM culprits and for useful SMs that could possibly be antibacterial against other pathogens (23).
To survive in a hospital setting, ESKAPE pathogens express SMs encoded by BGCs (24). These SMs include antibiotic and anti-biofilm compounds that act against certain bacteria in favor of others (24). On the clinical level, SMs may act in synergism with common AMR mechanisms such as efflux systems and thus render conventional antimicrobials ineffective (25). SMs can also act as antioxidants for reactive oxygen species (ROS), the unstable molecules that contain oxygen and cause cell damage (25). One example of an antioxidant SM is staphyloxanthin produced by S. aureus (26). Pyocyanin is a phenazine reduction oxidation SM produced by P. aeruginosa as a virulence factor in lung infections (27, 28). Accordingly, SM analysis was suggested to be considered in the standard antibiotic susceptibility tests (25, 29). In A. baumannii, wee BGC encodes for extracellular polysaccharide matrix. Targeting this cluster may prevent one of the highest virulence mechanisms of the bacterium, the biofilm (30).
Siderophores are SMs that help bacteria to quench the necessary iron needed for bacterial cells’ growth (31). Normally, host organisms do not have freely moving iron, but the iron is rather tightly bound to proteins. Bacteria can counteract the scarcity of iron by siderophore-dependent and siderophore-independent mechanisms (32). Siderophore production may affect the biofilm formation process in ESKAPE pathogens (31). Siderophores may also interfere with antibiotic activity by modulating oxidative stress mechanisms (33).
With the low-cost and time-efficient sequencing technologies, it is becoming easier to sequence the whole genome of an organism of interest. Whole-genome sequencing has become especially useful with bacteria to mine their genomes and reveal more of their sophisticated metabolic machinery. The therapeutic and industrial potential of BGCs and SMs motivated developers in the microbial bioinformatics field to implement new tools to predict the presence and structure of potential of BGCs within the sequence of bacterial genomes. Bioinformatics and chemoinformatics analysis tools are reviewed in reference (34) in detail.
We aimed to assess the potential of the genomes of selected clinically relevant Gram-negative species pertaining to the species: K. pneumoniae, P. aeruginosa, and A. baumannii, to produce SMs by detection of their potential BGCs. We focused on the clusters that were most abundant in each of the included taxa. The aim of this study was to detect the BGCs of the selected strains and align them with BGCs of known strains. In the future, it is needed to decipher the NPs they produce and their possible roles in the virulence of the strains.
MATERIALS AND METHODS
Sample collection, DNA extraction, and sequencing
An overview of the workflow is detailed in Fig. 1. A total of 66 isolates (17 P. aeruginosa, 28 K. pneumoniae, and 21 A. baumannii isolates) were recovered from different clinical specimens (blood, urine, sputum, and others). All samples were randomly collected from patients admitted to bacteriological testing at Mabaret El Asafra Labs, Alexandria, Egypt during the period between August 2020 and March 2021. Bacterial identification at the species level was carried out using the VITEK 2 Compact GN ID card (bioMérieux, Marcy-l’Étoile, France). DNA extraction was performed using QIAamp DNA Mini Kit (QIAGEN) according to the manufacturer’s instructions. DNA quality and concentration were determined using a Qubit 3.0 fluorometer. The Illumina NextSeq 550 sequencing platform was used for whole-genome sequencing of the isolates. For library preparation, 1 μg of genomic DNA and the NEXTflex Rapid XP DNA-Seq library Preparation Kit following the manufacturer’s instructions was used (PerkinElmer, https://perkinelmer-appliedgenomics.com/). The libraries were sequenced using the NextSeq system by NextSeq 500/550 mid output kit v2.5 (300 cycles) paired-end kit.
Fig 1.
Analysis pipeline workflow.
Assembly of the draft genomes
Raw paired-end reads of 76 bp length were filtered using fastp (35) with default parameters. Taxonomic classification of the samples was screened using Kmer Finder (36). Identification of strains of all the isolates was concluded using rMLST (37). Three representative strains for each species, based on higher abundance, were included in the analysis. They were PA790 (NZ_CP075176.1), SE5331 (NZ_CP046402.2), and ST773 (NZ_CP041945.1) for P. aeruginosa, B12AN (NZ_CABHKQ010000003.1), IR5065 (NZ_CP061948.1), and KpvST147B_SE1_1_NDM (NZ_CP040724.1) for K. pneumoniae, and ACN21 (NZ_CP038644.1), MS14413 (NZ_CP054302.1), and TP3 (NZ_CP060013.1) for A. baumannii, respectively. Complete FASTA files were downloaded for these representative strains from RefSeq database (38). Filtered reads were assembled using Unicycler software (39). Contigs assembly quality was assessed using QUAST (40). The metadata of the assembled contigs is detailed in Table S1 at https://github.com/lailaziko/Gram-Negative-BGCs.
Detection of BGCs
We used four bioinformatics tools for BGCs detection and analysis. The first one was antiSMASH software (v6.0.1), where detection strictness was set into relaxed (14). Algorithms used for BGCs searching were Known Cluster Blast, Active Site Binder, SubCluster Blast, and RREFinder. Selected BGCs were as follows: non-ribosomal peptide synthase (NRPS), RiPP-like, and siderophores, as they were the most abundant BGCs found in P. aeruginosa, K. pneumoniae, and A. baumannii, respectively. Using GenBank files generated from antiSMASH, the selected BGCs in the samples and representative strains were visualized using command-line Clinker software (41) where alignment was included, and the identity was set to 90%, clusters were labeled according to gene functions, and similar clusters were linked. A spectrum of colors was set for each gene cluster but only clusters of interest were annotated in the figure legends of Fig. 2 to 4; Fig. S1 to S8 at https://github.com/lailaziko/Gram-Negative-BGCs. As P. aeruginosa showed multiple NRPS regions in all the samples, Clinker presentation of NRPS was divided on multiple panels (Fig. 4; Fig. S1 to S8 at https://github.com/lailaziko/Gram-Negative-BGCs). Clinker automatically assigns colors for homologous genes as provided by GenBank files output from antiSMASH software. As samples for each species were analyzed independently, different colors might be assigned. Therefore, a detailed color legend for each figure was provided. Some samples encoded similar BGCs but not homologous—i.e., not aligning—for Clinker to assign them all the same color. To further check Clinker output, we manually curated the BGC Genbank files generated by antiSMASH to match with Clinker and gray-colored clustered were re-colored if they presented BGCs of interest.
Fig 2.
Siderophore BGCs in Acinetobacter baumannii. The colors in the legend indicate the biosynthetic gene clusters of interest. Other colors are either of unknown function or not the main aim of the current study. The letter “S” stands for the sample, followed by the sample number, then the contig number, then the base pair position of the BGC on this contig.
Fig 4.
NRPS BGC subgroup 1 in Pseudomonas aeruginosa. Other NRPS subgroups in Pseudomonas aeruginosa isolates are grouped according to alignment and similarity and provided in the figures at https://github.com/lailaziko/Gram-Negative-BGCs.
Fig 5.
Hierarchical clustering of the bacteria based on their BGC profiles: (A) Acinetobacter baumannii, (B) Klebsiella pneumoniae, and (C) Pseudomonas aeruginosa.
To infer the chemical structure of the selected BGCs and further detect other putative BGCs, PRISM software (42) was utilized with default parameters used for the analysis needed. GECCO was used to (43) analyze the assembled contigs for de novo BGCs and BAGEL was employed (44) for RiPPs and bacteriocin detection.
Data analysis
R was used for the hierarchical classification of the detected BGCs. The normalization was done by dividing each number by the genome size and multiplied it by 106. The heatmap3 package was used for the generation of the heatmaps (45).
RESULTS
BGCs in P. aeruginosa draft genomes
In total, 590 BGCs were detected by antiSMASH in all the included genomes. Among those, 311 BGCs were detected in the included P. aeruginosa genomes. The most abundant BGC class was NRPS BGCs (117) in all screened isolates, also RiPP-like BGCs were detected in all 17 samples (39). The unique BGCs were NRPS-like_betalactone, Phenazine, NRPS_phenazine, N-acetylglutaminylglutamine amide (NAGGN), NRPS_NRPS-like_betalactone, and CDPS BGCs. All the detected normalized BGCs are shown in the heatmap (Fig. 5C). The detailed BGCs detected by antiSMASH are in Table S2 at https://github.com/lailaziko/Gram-Negative-BGCs. We selected the NRPS BGCs to display the alignment of the detected BGCs as per Clinker visualization tool (Fig. 4; Fig. S1 to S8 at https://github.com/lailaziko/Gram-Negative-BGCs ).
Fig 7.
BAGEL results for all isolates of each species.
GECCO detected 136 BGCs in P. aeruginosa genomes, with non-ribosomal peptides (NRPs) (77), Unknown (55), RiPP (2), and Saccharide (2) BGCs (Fig. 6 ; Fig. S9 at https://github.com/lailaziko/Gram-Negative-BGCs). PRISM detected 209 BGCs detailed in Table S3 at https://github.com/lailaziko/Gram-Negative-BGCs, and 178 structures were predicted. BAGEL revealed a total of 59 hits with P. aeruginosa isolates, and they were as follows (Fig. 7; Fig. S10 at https://github.com/lailaziko/Gram-Negative-BGCs): sactipeptides (23), bottromycin (13), 83.3;PaeM (2), colicin_E6 (4), 87.3;putidacin_L1 (2), pyocin_S2 (3), colicin (2), colicin-10 (2), pyocin_AP41_subunit (3), putidacin_L1 (2), zoocin_A (1), pyocin_S1 (1), and PaeM (1).
Fig 6.
GECCO results for all isolates of each species.
BGCs in A. baumannii draft genomes
A total of 133 BGCs were detected in the A. baumannii genomes. The most abundant BGC classes were Arylpolyene (26) and Siderophore (25) BGCs in 20 of the 21 screened A. baumannii isolates. The unique BGCs were NRPS_hserlactone (10), NAPAA (18), and NAPAA_betalactone (1). All the detected normalized BGCs are shown in the heatmap (Fig. 5A). The detailed BGCs detected by antiSMASH are in Table S2 at https://github.com/lailaziko/Gram-Negative-BGCs.
We selected the siderophore BGCs to display the alignment of the detected BGCs as per Clinker visualization tool (Fig. 2). GECCO detected 76 BGCs in A. baumannii, genomes, with NRP (41), Unknown (29), Saccharide (2), and Polyketide (4) BGCs (Fig. 6; Fig. S9 at https://github.com/lailaziko/Gram-Negative-BGCs). PRISM detected 70 clusters detailed in Table S3 at https://github.com/lailaziko/Gram-Negative-BGCs, and 45 structures were predicted. BAGEL revealed the least hits with A. baumannii isolates (Fig. 7; Fig. S10 at https://github.com/lailaziko/Gram-Negative-BGCs), with a total of 18 hits, and they were mainly lassopeptides (13), sactipeptides (4), and 18.3;Colicin_E6 (1).
Fig 3.
RiPP-like BGCs in Klebsiella pneumoniae. Colors that are not present in the legend represent gene clusters of functions other than BGCs.
BGCs in K. pneumoniae draft genomes
A total of 146 BGCs were detected in the K. pneumoniae genomes. The most abundant BGC class was RiPP-like (35) in 27 of the 28 screened isolates. The unique BGCs were T1PKS (7) and NRPS_T1PKS (5) BGCs. All the detected normalized BGCs are shown in the heatmap (Fig. 5B). The detailed BGCs detected by antiSMASH are shown in Table S2 at https://github.com/lailaziko/Gram-Negative-BGCs.
We selected the RiPP-like BGCs to display the alignment of the detected BGCs as per Clinker visualization tool (Fig. 3). GECCO detected 100 BGCs in K. pneumoniae genomes, with NRP (40), Unknown (26), RiPP (3), Saccharide (21), Polyketide (1), and NRP_Polyketide (9) BGCs (Fig. 6; Fig. S9 at https://github.com/lailaziko/Gram-Negative-BGCs). PRISM detected 87 clusters detailed in Table S3 at https://github.com/lailaziko/Gram-Negative-BGCs, and 47 structures were predicted. BAGEL revealed a total of 58 hits with K. pneumoniae isolates, and they were as follows (Fig. 7 and S10 at https://github.com/lailaziko/Gram-Negative-BGCs): sactipeptides (34), bottromycin (13), Colicin_E6 (5), 18.3;Colicin_E6 (4), 11.3;Colicin (one cluster), and ComX4 (1).
DISCUSSION
NRPS BGCs in P. aeruginosa draft genomes
Three NRPS BGCs are well-characterized in P. aeruginosa species standard strain PA01, and they encode for the formation of pyoverdine (the siderophore key player associated with pathogenesis), pyochelin (a siderophore produced by P. aeruginosa), L-2-Amino-4-methoxy-trans-3-butenoic acid (AMB) (involved in quorum sensing), pyoluteorin (an antibacterial compound), in addition to three uncharacterized NRPS BGCs (46). Recently, a mimic of an NRPS pathway to produce mimics of the antibiotic brevicidine was changed to be a ribosomal pathway instead, and this highlights the importance of studying NRPSs and their products as antibacterial agents (47). Further analysis of the NRPS clusters in the strains included in this study is required, and the comparison with the well-characterized Pseudomonas NRPS BGCs, as well as unraveling their function, whether in their contribution to the strain’s virulence or to their possible application as antibacterial agents. The results from GECCO were aligning with the antiSMASH results for the P. aeruginosa genomes, as indeed the largest detected class was NRP and it was higher than those also detected in the genomes pertaining to K. pneumoniae and A. baumannii. This warrants further studying, and interestingly, the unknown clusters were the second largest class and require further studying as to what is being coded for, and whether they are cryptic or active BGCs. In general, for all the included strains, antiSMASH detected more BGCs than GECCO platform. Although the difference was most prominent with P. aeruginosa genomes (590 vs 136 BGCs), and the least with K. pneumoniae genomes (146 vs 100 BGCs), it could possibly be because of the inclusion of more BGC types in those strains included in the database of antiSMASH.
The hits obtained by BAGEL are worth pursuing experimentally. Sactipeptides and bottromycin warrant further experimental studying, as well as the unique clusters that were detected uniquely in isolates pertaining to this species. Sactipeptides were recently found to be produced by Streptomyces thermophilus strain and one—streptosactin—was recently characterized and exhibited antibacterial activity (48). Bottromycin is known for its antibacterial effect (49), however, perhaps finding similarity with it would lead to an SM that is antagonistic and in this context, contributing to the virulence of the strains. Perhaps because P. aeruginosa strains are predicted to encode primarily peptides, they had also the most detected hits in BAGEL, as it is a database specific for detection of bacteriocins and RiPPs (50). PaeM is a bacteriocin produced by P. aeruginosa strains (51), and it is worth investigating the hit in the included strains, and testing them for antibacterial effects. The detected pyocins are particularly interesting hits as they are reported bacteriocin types that assist the formation of biofilms and hence are virulence factors (52). Zoocin is also a bacteriocin (53), and it was detected in the included samples. Putidacin is a bacteriocin that is of the type of lectin-like (54). Colicins are bacteriocins that were studied in Escherichia coli (52), and their detection in this species is also worth pursuing.
The NRPS clusters abundant in P. aeruginosa isolates are depicted in Fig. 4; Fig. S1 to S8 at https://github.com/lailaziko/Gram-Negative-BGCs. They are mainly distributed among nine panels according to the alignment and are important for further comparisons, and it shows how there were different NRPS BGCs and thus were aligned differently. We attempted to group together the P. aeruginosa isolates for similar BGC signature profiles (Fig. 5C), and the closer strains cluster together in the heatmap into five main clusters. Table S3 at https://github.com/lailaziko/Gram-Negative-BGCs includes all the details about the hits obtained by PRISM, and 178 structures were predicted, some were basic structures while some were more detailed chemical structures. We herein report them as a lead together with their annotation in order to be used later for experimental analysis, they include mainly non-ribosomal peptides and acyl homoserine lactones, among other classes.
RiPP-like BGCs in K. pneumoniae draft genomes
RiPP-like clusters are detected by antiSMASH and comprise BGCs that are not detected as RiPPs but are however found regularly with RiPPs, including bacteriocins and other unspecified RiPPs (14). Bacteriocins have antibacterial activities and are peptidic in nature that are ribosomally synthesized (55). Bacteriocins were recently detected in Klebsiella genus and identified as klebicins, which are colicin-like bacteriocins (56). These klebicins were found to be effective against Klebsiella clinical isolates, in support that actually bacteriocins are effective against members of the ESKAPE pathogens (56). GECCO results were not in concordance with the antiSMASH results in this regard, as the majority of the detected BGCs comprised NRPs, followed by unknown clusters; however, this discrepancy could be explained by the naming each platform uses, in addition to the inherent workflow difference, that renders GECCO capable of predicting novel BGCs, rather than aligning with characterized BGCs. Interestingly, K. pneumoniae isolates harbored one putative polyketide and nine NRP_polyketide clusters, which were particularly unique and warrants further experimental validation. Future work on our data would encompass that the bacteriocin sequences are further analyzed and tested as to their potential antimicrobial effect.
The hits retrieved from BAGEL were close to the antiSMASH results, as sactipeptides were detected. Their role in pathogenicity as well as targeting them by genus-specific drugs in the future are worth investigating. Bottromycin hits need also further studying, as well as the uniquely detected hits. ComX4 is a RiPP that is involved in surfactin synthesis by being a quorum-sensing player (57), and should be investigated for its role in the included K. pneumoniae genomes. Sactipeptide, bottromycin, and colicin BGCs were also recently reported in clinical isolates of Klebsiella in Thailand (58).
The RiPP-like BGCs which were most common among the K. pneumoniae genomes were aligned and are depicted in Fig. 3, with the similar BGCs aligned together. Among the detected clusters such as RiPP-like cloacin, which is a bacteriocin and coincides in its class with the BAGEL results (59). RiPP-like TIGR03651 was also detected, which belongs to the circular bacteriocin, circularin A/uberolysin family (60). Biosynthetic aminoglycoside phosphotransferase (APH) genes were found, which were earlier reported in the biosynthesis of thiostreptamide S4 which belongs to the anticancer class of compounds, the thioamitide class (61), and hence warrants further investigation. We attempted to group together the K. pneumoniae isolates for similar BGC signature profiles (Fig. 2B), and the closer strains cluster together in the heatmap into four main clusters. Table S2 at https://github.com/lailaziko/Gram-Negative-BGCs includes all the details about the hits obtained by PRISM, and 51 structures were predicted, some were basic structures, and some were more detailed chemical structures. We herein report them as a lead together with their annotation in order to be used later for experimental analysis, they include mainly non-ribosomal peptides, polyketides, NRPS-independent siderophore synthases, and polyketide-non-ribosomal peptides, among other classes.
Siderophore and aryl polyene BGCs in A. baumannii draft genomes
Siderophore BGCs were recently detected in Nocardia species and possibly contributing to their pathogenicity (62). Recently it was found that A. baumannii utilize several siderophores mainly to bind iron and hence are harboring multiple siderophore BGCs, and one particular siderophore is pertaining to its virulence, namely acinetobactin (63). There are up to 10 siderophore BGCs within A. baumannii genomes (63). The included strains harbored siderophore BGCs in common and their alignment with known A. baumannii BGCs remains to be investigated, as well as their roles in the strain virulence. Aryl polyene BGCs were detected within the genome of the virulent Acinetobacter strain global clone 2 (GC2) (64). Aryl polyene BGCs code for the production of 4-hydroxybenzoyl polyene compounds, and they have a hypothesized function to escape the host immune system (64). The aryl polyene BGCs detected in this study require further analysis as to their similarity to characterized aryl polyene BGCs of other strains and their role to be investigated. The GECCO results were not in concordance with the antiSMASH detected BGCs, as the most BGCs were detected as NRPs, which could possibly be because of the different classes detected by each tool, and that GECCO types are more limited than antiSMASH BGC types that could be detected. It is noteworthy that 29 unknown BGCs were detected as well as four polyketides, which points toward their study and might explain those detected by antiSMASH as well as additional ones.
It is noteworthy that the lasso peptides are prominent in this genus, as well as the unique clusters detected. The functions of the detected clusters need to be deciphered, as to their role in virulence and could be possible targets for drugs towards these specific strains. Lasso peptides were earlier produced by other Acinetobacter strains, such as A. gyllenbergii, that produce acinetodin (65). Sactipeptides and colicins are also bacteriocins as mentioned earlier, and their role in pathogenicity as well as possible antibacterial effects need to be further investigated.
The siderophores were most commonly detected in A. baumannii genomes and their alignment is depicted in Fig. 2. lucA//lucC gene family hits were detected in the siderophore BGCs as it is an iron uptake chelate domain involved in siderophores biosynthesis. lucA and lucC are ligases and NRPS-independent siderophore synthetases that were previously studied in hypervirulent K. pneumoniae (66). We attempted to group together the A. baumannii genomes for similar BGC signature profiles (Fig. 5A), and the closer strains cluster together in the heatmap into two main clusters. Table S3 at https://github.com/lailaziko/Gram-Negative-BGCs includes all the details about the hits obtained by PRISM, and 45 structures were predicted, some were basic structures, and some were more detailed chemical structures. We herein report them as a lead together with their annotation to be used later for experimental analysis, they include mainly non-ribosomal peptides, NRPS-independent siderophore synthases, acyl homoserine lactone-non-ribosomal peptide, and acyl homoserine lactones, among other classes.
In conclusion, our study investigates the BGCs present in three members of the ESKAPE pathogen panel that are relevant in hospitals and has highlighted the most common BGC type in each of the A. baumannii, K. pneumoniae, and P. aeruginosa strains. We predict those BGCs perhaps play a specific role in the virulence of each strain, which warrants further experimental validation. Several isolates of the same species were analyzed to study the similarities and differences between their encoded BGCs. The BGCs pertaining to the same species indeed show differences as visualized in Fig. 2 to 7; Fig. S1 to S8 at https://github.com/lailaziko/Gram-Negative-BGCs, with the common and different BGCs indicated. There is a common signature BGC profile for each species; however, there were inter-species differences with regard to their BGCs.
ACKNOWLEDGMENTS
The authors would like to deeply thank Aya Galal (American University in Cairo) for her help in generating the heatmaps.
Contributor Information
Laila Ziko, Email: l.adel@gaf.edu.eg.
Mark William Pandori, Nevada State Public Health Laboratory, Reno, Nevada, USA .
DATA AVAILABILITY
The raw reads were deposited in NCBI under the Bioprojects: PRJNA906142, PRJNA906139, and PRJNA906141 for P. aeruginosa, K. pneumoniae, and A. baumannii, respectively. The accession numbers of the representative strains used are as aforementioned. The supplementary files are available online at: https://github.com/lailaziko/Gram-Negative-BGCs.
ETHICS APPROVAL
The study represents a retrospective study that involves molecular characterization of historical strains collected during the study period. No patient data collection was involved in this study.
REFERENCES
- 1. Rice LB. 2008. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 197:1079–1081. doi: 10.1086/533452 [DOI] [PubMed] [Google Scholar]
- 2. Antibiotic resistance threats in the United States. 2019. Centers for Disease Control and Prevention. [cited 2022 Dec 12]. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
- 3. WHO publishes list of bacteria for which new antibiotics are urgently needed [Internet]. World Health Organization (WHO). [cited 2022 Dec 12]. Available from: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed
- 4. De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. 2020. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev 33:e00181-19. doi: 10.1128/CMR.00181-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, Blair JMA. 2023. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol 21:280–295. doi: 10.1038/s41579-022-00820-y [DOI] [PubMed] [Google Scholar]
- 6. Paterson DL, Bonomo RA. 2005. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18:657–686. doi: 10.1128/CMR.18.4.657-686.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Zapun A, Contreras-Martel C, Vernet T. 2008. Penicillin-binding proteins and β-lactam resistance. FEMS Microbiol Rev 32:361–385. doi: 10.1111/j.1574-6976.2007.00095.x [DOI] [PubMed] [Google Scholar]
- 8. Stapleton PD, Taylor PW. 2002. Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog 85:57–72. doi: 10.3184/003685002783238870 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Sabry NA, Farid SF, Dawoud DM. 2014. Antibiotic dispensing in Egyptian community pharmacies: an observational study. Res Social Adm Pharm 10:168–184. doi: 10.1016/j.sapharm.2013.03.004 [DOI] [PubMed] [Google Scholar]
- 10. Wall S. 2019. Prevention of antibiotic resistance – an epidemiological scoping review to identify research categories and knowledge gaps. Glob Health Action 12:1756191. doi: 10.1080/16549716.2020.1756191 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Jensen PR, Chavarria KL, Fenical W, Moore BS, Ziemert N. 2014. Challenges and triumphs to genomics-based natural product discovery. J Ind Microbiol Biotechnol 41:203–209. doi: 10.1007/s10295-013-1353-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Jensen PR. 2016. Natural products and the gene cluster revolution. Trends Microbiol 24:968–977. doi: 10.1016/j.tim.2016.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Junkins EN, McWhirter JB, McCall L-I, Stevenson BS. 2022. Environmental structure impacts microbial composition and secondary metabolism. ISME Commun 2. doi: 10.1038/s43705-022-00097-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Blin K, Shaw S, Kloosterman AM, Charlop-Powers Z, van Wezel GP, Medema MH, Weber T. 2021. antiSMASH 6.0: improving cluster detection and comparison capabilities. Nucleic Acids Res 49:W29–W35. doi: 10.1093/nar/gkab335 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Davies J. 2013. Specialized microbial metabolites: functions and origins. J Antibiot (Tokyo) 66:361–364. doi: 10.1038/ja.2013.61 [DOI] [PubMed] [Google Scholar]
- 16. Davies J, Ryan KS. 2012. Introducing the parvome: bioactive compounds in the microbial world. ACS Chem Biol 7:252–259. doi: 10.1021/cb200337h [DOI] [PubMed] [Google Scholar]
- 17. Newman DJ, Cragg GM. 2020. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod 83:770–803. doi: 10.1021/acs.jnatprod.9b01285 [DOI] [PubMed] [Google Scholar]
- 18. Scharf DH, Heinekamp T, Brakhage AA. 2014. Human and plant fungal pathogens: the role of secondary metabolites. PLoS Pathog 10:e1003859. doi: 10.1371/journal.ppat.1003859 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Díaz-Cruz GA, Liu J, Tahlan K, Bignell DRD. 2022. Nigericin and geldanamycin are phytotoxic specialized metabolites produced by the plant pathogen Streptomyces sp. 11-1-2. Microbiol Spectr 10:e0231421. doi: 10.1128/spectrum.02314-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Mollah MMI, Kim Y. 2020. Virulent secondary metabolites of entomopathogenic bacteria genera, xenorhabdus and photorhabdus, inhibit phospholipase A2 to suppress host insect immunity. BMC Microbiol 20:359. doi: 10.1186/s12866-020-02042-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Lybbert AC, Williams JL, Raghuvanshi R, Jones AD, Quinn RA. 2020. Mining public mass spectrometry data to characterize the diversity and ubiquity of P. aeruginosa specialized metabolites. Metabolites 10:445. doi: 10.3390/metabo10110445 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Elshafie HS, Camele I. 2021. An overview of metabolic activity, beneficial and pathogenic aspects of Burkholderia Spp. Metabolites 11:321. doi: 10.3390/metabo11050321 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Maglangit F, Yu Y, Deng H. 2021. Bacterial pathogens: threat or treat (a review on bioactive natural products from bacterial pathogens). Nat Prod Rep 38:782–821. doi: 10.1039/d0np00061b [DOI] [PubMed] [Google Scholar]
- 24. Tiwari V, Meena K, Tiwari M. 2018. Differential anti-microbial secondary metabolites in different ESKAPE pathogens explain their adaptation in the hospital setup. Infect Genet Evol 66:57–65. doi: 10.1016/j.meegid.2018.09.010 [DOI] [PubMed] [Google Scholar]
- 25. Perry EK, Meirelles LA, Newman DK. 2022. From the soil to the clinic: the impact of microbial secondary metabolites on antibiotic tolerance and resistance. Nat Rev Microbiol 20:129–142. doi: 10.1038/s41579-021-00620-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Clauditz A, Resch A, Wieland K-P, Peschel A, Götz F. 2006. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 74:4950–4953. doi: 10.1128/IAI.00204-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Lau GW, Hassett DJ, Ran H, Kong F. 2004. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 10:599–606. doi: 10.1016/j.molmed.2004.10.002 [DOI] [PubMed] [Google Scholar]
- 28. Zhu K, Chen S, Sysoeva TA, You L, Balaban N. 2019. Universal antibiotic tolerance arising from antibiotic-triggered accumulation of pyocyanin in Pseudomonas aeruginosa. Edited by Balaban N. PLoS Biol 17:e3000573. doi: 10.1371/journal.pbio.3000573 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Meirelles LA, Newman DK. 2022. Phenazines and toxoflavin act as interspecies modulators of resilience to diverse antibiotics. Mol Microbiol 117:1384–1404. doi: 10.1111/mmi.14915 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Tiwari M, Panwar S, Kothidar A, Tiwari V. 2020. Rational targeting of Wzb phosphatase and Wzc kinase interaction inhibits extracellular polysaccharides synthesis and biofilm formation in Acinetobacter baumannii. Carbohydr Res 492:108025. doi: 10.1016/j.carres.2020.108025 [DOI] [PubMed] [Google Scholar]
- 31. Post SJ, Shapiro JA, Wuest WM. 2019. Connecting iron acquisition and biofilm formation in the ESKAPE pathogens as a strategy for combatting antibiotic resistance. Medchemcomm 10:505–512. doi: 10.1039/c9md00032a [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Tiwari V. 2013. Effect of iron availability on the survival of carbapenem-resistant Acinetobacter baumannii: a proteomic approach. J Proteomics Bioinform 06:06. doi: 10.4172/jpb.1000270 [DOI] [Google Scholar]
- 33. Lazar V, Holban AM, Curutiu C, Chifiriuc MC. 2021. Modulation of quorum sensing and biofilms in less investigated gram-negative ESKAPE pathogens. Front Microbiol 12:676510. doi: 10.3389/fmicb.2021.676510 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Kim HU, Blin K, Lee SY, Weber T. 2017. Recent development of computational resources for new antibiotics discovery. Curr Opin Microbiol 39:113–120. doi: 10.1016/j.mib.2017.10.027 [DOI] [PubMed] [Google Scholar]
- 35. Chen S, Zhou Y, Chen Y, Gu J. 2018. fastp: an ultra-fast all-in-one FASTQ Preprocessor. Bioinformatics 34:i884–i890. doi: 10.1093/bioinformatics/bty560 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Clausen P, Aarestrup FM, Lund O. 2018. Rapid and precise alignment of raw reads against redundant databases with KMA. BMC Bioinformatics 19:307. doi: 10.1186/s12859-018-2336-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Jolley KA, Bliss CM, Bennett JS, Bratcher HB, Brehony C, Colles FM, Wimalarathna H, Harrison OB, Sheppard SK, Cody AJ, Maiden MCJ. 2012. Ribosomal multilocus sequence typing: universal characterization of bacteria from domain to strain. Microbiology (Reading) 158:1005–1015. doi: 10.1099/mic.0.055459-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. O’Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, Ako-Adjei D, Astashyn A, Badretdin A, Bao Y, Blinkova O, Brover V, Chetvernin V, Choi J, Cox E, Ermolaeva O, Farrell CM, Goldfarb T, Gupta T, Haft D, Hatcher E, Hlavina W, Joardar VS, Kodali VK, Li W, Maglott D, Masterson P, McGarvey KM, Murphy MR, O’Neill K, Pujar S, Rangwala SH, Rausch D, Riddick LD, Schoch C, Shkeda A, Storz SS, Sun H, Thibaud-Nissen F, Tolstoy I, Tully RE, Vatsan AR, Wallin C, Webb D, Wu W, Landrum MJ, Kimchi A, Tatusova T, DiCuccio M, Kitts P, Murphy TD, Pruitt KD. 2016. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res 44:D733–D745. doi: 10.1093/nar/gkv1189 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. doi: 10.1371/journal.pcbi.1005595 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29:1072–1075. doi: 10.1093/bioinformatics/btt086 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Gilchrist CLM, Chooi Y-H. 2021. Clinker & Clustermap.Js: automatic generation of gene cluster comparison figures. Bioinformatics 37:2473–2475. doi: 10.1093/bioinformatics/btab007 [DOI] [PubMed] [Google Scholar]
- 42. Skinnider MA, Johnston CW, Gunabalasingam M, Merwin NJ, Kieliszek AM, MacLellan RJ, Li H, Ranieri MRM, Webster ALH, Cao MPT, Pfeifle A, Spencer N, To QH, Wallace DP, Dejong CA, Magarvey NA. 2020. Comprehensive prediction of secondary metabolite structure and biological activity from microbial genome sequences. Nat Commun 11:6058. doi: 10.1038/s41467-020-19986-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Carroll LM, Larralde M, Fleck JS, Ponnudurai R, Milanese A, Cappio E, Zeller G. 2021. Accurate de novo identification of biosynthetic gene clusters with GECCO . bioRxiv. doi: 10.1101/2021.05.03.442509 [DOI]
- 44. de Jong A, van Hijum SAFT, Bijlsma JJE, Kok J, Kuipers OP. 2006. BAGEL: a web-based bacteriocin genome mining tool. Nucleic Acids Res 34:W273–9. doi: 10.1093/nar/gkl237 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Zhao S, Guo Y, Sheng Q, Shyr Y. 2014. Heatmap3: an improved heatmap package with more powerful and convenient features. BMC Bioinformatics 15. doi: 10.1186/1471-2105-15-S10-P16 [DOI] [Google Scholar]
- 46. Gulick AM. 2017. Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens. Nat Prod Rep 34:981–1009. doi: 10.1039/c7np00029d [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Zhao X, Li Z, Kuipers OP. 2020. Mimicry of a non-ribosomally produced antimicrobial, brevicidine, by ribosomal synthesis and post-translational modification. Cell Chem Biol 27:1262–1271. doi: 10.1016/j.chembiol.2020.07.005 [DOI] [PubMed] [Google Scholar]
- 48. Bushin LB, Covington BC, Rued BE, Federle MJ, Seyedsayamdost MR. 2020. Discovery and biosynthesis of streptosactin, a sactipeptide with an alternative topology encoded by commensal bacteria in the human microbiome. J Am Chem Soc 142:16265–16275. doi: 10.1021/jacs.0c05546 [DOI] [PubMed] [Google Scholar]
- 49. Shimamura H, Gouda H, Nagai K, Hirose T, Ichioka M, Furuya Y, Kobayashi Y, Hirono S, Sunazuka T, Omura S. 2009. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE. Angew Chem Int Ed Engl 48:914–917. doi: 10.1002/anie.200804138 [DOI] [PubMed] [Google Scholar]
- 50. van Heel AJ, de Jong A, Song C, Viel JH, Kok J, Kuipers OP. 2018. BAGEL4: a user-friendly web server to thoroughly mine RiPPs and bacteriocins. Nucleic Acids Res 46:W278–W281. doi: 10.1093/nar/gky383 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Barreteau H, Tiouajni M, Graille M, Josseaume N, Bouhss A, Patin D, Blanot D, Fourgeaud M, Mainardi J-L, Arthur M, van Tilbeurgh H, Mengin-Lecreulx D, Touzé T. 2012. Functional and structural characterization of PaeM, a colicin M-like bacteriocin produced by Pseudomonas aeruginosa. J Biol Chem 287:37395–37405. doi: 10.1074/jbc.M112.406439 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Ghequire MGK, Öztürk B. 2018. A colicin M-type bacteriocin from Pseudomonas aeruginosa targeting the HxuC Heme receptor requires a novel immunity partner. Appl Environ Microbiol 84:1–11. doi: 10.1128/AEM.00716-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Costa SS, Lago LAB, Silva A, Graças DA das, Lameira J, Baraúna RA. 2022. Diversity of bacteriocins in the microbiome of the Tucuruí hydroelectric power plant water reservoir and three-dimensional structure prediction of a zoocin. Genet Mol Biol 45:e20210204. doi: 10.1590/1678-4685-GMB-2021-0204 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Rooney WM, Chai R, Milner JJ, Walker D. 2020. Bacteriocins targeting gram-negative phytopathogenic bacteria: plantibiotics of the future. Front Microbiol 11:575981. doi: 10.3389/fmicb.2020.575981 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Yang SC, Lin CH, Sung CT, Fang JY. 2014. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol 5:683. doi: 10.3389/fmicb.2014.00683 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Denkovskienė E, Paškevičius Š, Misiūnas A, Stočkūnaitė B, Starkevič U, Vitkauskienė A, Hahn-Löbmann S, Schulz S, Giritch A, Gleba Y, Ražanskienė A. 2019. Broad and efficient control of Klebsiella pathogens by peptidoglycan-degrading and pore-forming bacteriocins klebicins. Sci Rep 9:15422. doi: 10.1038/s41598-019-51969-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Petrillo C, Castaldi S, Lanzilli M, Selci M, Cordone A, Giovannelli D, Isticato R. 2021. Genomic and physiological characterization of bacilli isolated from salt-pans with plant growth promoting features. Front Microbiol 12:715678. doi: 10.3389/fmicb.2021.715678 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Chukamnerd A, Pomwised R, Jeenkeawpiam K, Sakunrang C, Chusri S, Surachat K. 2022. Genomic insights into blaNDM-carrying carbapenem-resistant Klebsiella pneumoniae clinical isolates from a university hospital in Thailand. Microbiol Res 263:127136. doi: 10.1016/j.micres.2022.127136 [DOI] [PubMed] [Google Scholar]
- 59. Rebuffat S. 2011. Bacteriocins from gram-negative bacteria: a classification?, p 55–72. In Prokaryotic antimicrobial peptides. doi: 10.1007/978-1-4419-7692-5 [DOI] [Google Scholar]
- 60. Lu S, Wang J, Chitsaz F, Derbyshire MK, Geer RC, Gonzales NR, Gwadz M, Hurwitz DI, Marchler GH, Song JS, Thanki N, Yamashita RA, Yang M, Zhang D, Zheng C, Lanczycki CJ, Marchler-Bauer A. 2020. CDD/SPARCLE: the conserved domain database in 2020. Nucleic Acids Res 48:D265–D268. doi: 10.1093/nar/gkz991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Eyles TH, Vior NM, Lacret R, Truman AW. 2021. Understanding thioamitide biosynthesis using pathway engineering and untargeted metabolomics. Chem Sci 12:7138–7150. doi: 10.1039/d0sc06835g [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Engelbrecht A, Saad H, Gross H, Kaysser L. 2021. Natural products from nocardia and their role in pathogenicity. Microb Physiol 31:217–232. doi: 10.1159/000516864 [DOI] [PubMed] [Google Scholar]
- 63. Sheldon JR, Skaar EP, Weiss DS. 2020. Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence. PLoS Pathog. 16:e1008995. doi: 10.1371/journal.ppat.1008995 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Lee WC, Choi S, Jang A, Yeon J, Hwang E, Kim Y. 2021. Structural basis of the complementary activity of two ketosynthases in aryl polyene biosynthesis. Sci Rep 11:16340. doi: 10.1038/s41598-021-95890-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Metelev M, Arseniev A, Bushin LB, Kuznedelov K, Artamonova TO, Kondratenko R, Khodorkovskii M, Seyedsayamdost MR, Severinov K. 2017. Acinetodin and klebsidin, RNA polymerase targeting lasso peptides produced by human isolates of Acinetobacter gyllenbergii and Klebsiella pneumoniae. ACS Chem Biol 12:814–824. doi: 10.1021/acschembio.6b01154 [DOI] [PubMed] [Google Scholar]
- 66. Bailey DC, Alexander E, Rice MR, Drake EJ, Mydy LS, Aldrich CC, Gulick AM. 2018. Structural and functional delineation of aerobactin biosynthesis in hypervirulent Klebsiella pneumoniae. J Biol Chem 293:7841–7852. doi: 10.1074/jbc.RA118.002798 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The raw reads were deposited in NCBI under the Bioprojects: PRJNA906142, PRJNA906139, and PRJNA906141 for P. aeruginosa, K. pneumoniae, and A. baumannii, respectively. The accession numbers of the representative strains used are as aforementioned. The supplementary files are available online at: https://github.com/lailaziko/Gram-Negative-BGCs.







